VTT research exploits metabolics

VTT is seeking to create new development paths towards a healthier life. New opportunities created by metabolics in the fields of diagnostics, medical development, industrial biotechnology and environmental technology have been a part of VTT research for almost 10 years.

VTT is one of the organisers of Metabomeeting 2011, an international conference on metabolics that has been held at the end of September. Professor Jeremy K. Nicholson from London Imperial College has opened the conference on Sunday, 25 September.

Metabolics is a new field concerned with human metabolites and their behaviour, and their impact on human health and well-being. The technology has already advanced development work on the treatment of many types of cancer, type 1 diabetes, obesity and obesity diseases, and schizophrenia. Metabolics has also assisted in finding new drug targets in cancer treatment, with medicines already entering production.

VTT's research has been exploiting metabolics for almost ten years. Research Professor Matej Oresic sees a bright future: "Its significance for health and well-being is increasing rapidly, and metabolics already plays a key role in the development of personal health care. We have discovered a number of biomarkers that will help in predicting serious diseases."

Source VTT

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy